(Q34656182)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17654759%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

title

Structure-activity relationships for a family of benzothiophene selective estrogen receptor modulators including raloxifene and arzoxifene (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17654759%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

1 reference

Cassia R Overk

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17654759%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Kuan-Wei Peng

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17654759%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Rezene T Asghodom

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17654759%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Daniel D Lantvit

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17654759%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Zhihui Qin

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17654759%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Jonna Frasor

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17654759%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Gregory R J Thatcher

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17654759%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

publication date

1 October 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17654759%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17654759%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

volume

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17654759%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17654759%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

page(s)

1520-1526

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17654759%20AND%20SRC:MED&resulttype=core&format=json

SERMs in chemoprevention of breast cancer

2 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700104

7 January 2021

Risk and prognosis of endometrial cancer after tamoxifen for breast cancer. Comprehensive Cancer Centres' ALERT Group. Assessment of Liver and Endometrial cancer Risk following Tamoxifen

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700104

7 January 2021

The G protein-coupled receptor GPR30 mediates the proliferative effects induced by 17beta-estradiol and hydroxytamoxifen in endometrial cancer cells

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700104

7 January 2021

Understanding the genotoxicity of tamoxifen?

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700104

7 January 2021

Genotoxic mechanism of tamoxifen in developing endometrial cancer

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700104

7 January 2021

Synthesis and reactivity of a potential carcinogenic metabolite of tamoxifen: 3,4-dihydroxytamoxifen-o-quinone

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700104

7 January 2021

Bioactivation of Selective Estrogen Receptor Modulators (SERMs)

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700104

7 January 2021

Oxidation of raloxifene to quinoids: potential toxic pathways via a diquinone methide and o-quinones

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700104

7 January 2021

Bioactivation of the selective estrogen receptor modulator desmethylated arzoxifene to quinoids: 4'-fluoro substitution prevents quinoid formation.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700104

7 January 2021

Chemical modification modulates estrogenic activity, oxidative reactivity, and metabolic stability in 4'F-DMA, a new benzothiophene selective estrogen receptor modulator

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700104

7 January 2021

Benzothiophene selective estrogen receptor modulators with modulated oxidative activity and receptor affinity

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700104

7 January 2021

Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700104

7 January 2021

Effects of raloxifene on cardiovascular events and breast cancer in postmenopausal women

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700104

7 January 2021

Arzoxifene as therapy for endometrial cancer

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700104

7 January 2021

Arzoxifene: the development and clinical outcome of an ideal SERM.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700104

7 January 2021

Molecular determinants of tissue selectivity in estrogen receptor modulators

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700104

7 January 2021

Structure-activity relationships of selective estrogen receptor modulators: modifications to the 2-arylbenzothiophene core of raloxifene

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700104

7 January 2021

Profiling of estrogen up- and down-regulated gene expression in human breast cancer cells: insights into gene networks and pathways underlying estrogenic control of proliferation and cell phenotype

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700104

7 January 2021

A monohydroxylated metabolite of tamoxifen with potent antioestrogenic activity

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700104

7 January 2021

Induction of NAD(P)H quinone oxidoreductase and glutathione S-transferase activities in livers of female August-Copenhagen Irish rats treated chronically with estradiol: comparison with the Sprague-Dawley rat

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700104

7 January 2021

Discovery and synthesis of [6-hydroxy-3-[4-[2-(1-piperidinyl)ethoxy]phenoxy]-2-(4-hydroxyphenyl)]b enzo[b]thiophene: a novel, highly potent, selective estrogen receptor modulator

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700104

7 January 2021

Effects of long‐term administration of N‐3 polyunsaturated fatty acids (PUFA) and selective estrogen receptor modulator (SERM) derivatives in ovariectomized (OVX) mice

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700104

7 January 2021

Structural basis for an unexpected mode of SERM-mediated ER antagonism

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700104

7 January 2021

Raloxifene and ICI182,780 increase estrogen receptor-alpha association with a nuclear compartment via overlapping sets of hydrophobic amino acids in activation function 2 helix 12.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700104

7 January 2021

Hormone- and DNA-binding mechanisms of the recombinant human estrogen receptor

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700104

7 January 2021

Evaluation of estrogenic activity of plant extracts for the potential treatment of menopausal symptoms

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700104

7 January 2021

Identifiers

DOI

10.1002/CMDC.200700104

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17654759%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

1 reference